Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd

Next 500 2024
+ 3 More
+ 3 More
OVERVIEW
FINANCIALS

About

Dishman Carbogen Amcis Limited is a global pharmaceutical company specializing in active pharmaceutical ingredients (APIs) and contract development and manufacturing services (CDMO). With operations spanning multiple countries, the company provides high-quality, cost-effective solutions to pharmaceutical and biotechnology firms worldwide. It focuses on innovation, offering a comprehensive range of services from early-stage drug development to commercial-scale production. Dishman’s expertise in complex chemistry, regulatory compliance, and custom synthesis enables it to cater to diverse therapeutic segments. By integrating cutting-edge technology and a strong R&D foundation, the company plays a crucial role in the global pharmaceutical supply chain.

Incorporation Year: 2007
Headquarters: Ahmedabad, India
Top Management: Arpit J. Vyas (Global Managing Director)
Industry: Pharma
Website: imdcal.com

Featured In Fortune India Ranking

#476(2020)
Next 500 India
#136(2024)#6(2022)#11(2020)
#136(2024)#6(2022)#11(2020)
Ranking Trend Fortune Next 500 India

Financial Data 2024

Revenue
2,648
(INR Cr)
Net Operating Income
2,616
(INR Cr)
Assets
8,768
(INR Cr)
Profit
-153
(INR Cr)
Net Worth
5,628
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS2024202320222021202020192018201720162015
Revenue
(INR Cr)
2648
3.7%
2554
16.3%
2197
14.6%
1917
-9.0%
2106
0.9%
2087
15.6%
1806
3.8%
1740
-
7
1484.4%
0
-
Net Operating Income
(INR Cr)
2616
8.41%
2413
12.72%
2141
11.96%
1912
-6.44%
2044
-0.73%
2059
21.47%
1695
-1.10%
1714
0.00%
7
0.00%
0
0.00%
Profit
(INR Cr)
-153
-
-30
-
18
-
-165
-
159
-24.6%
210
36.1%
155
6.3%
145
-
1
-
-1
-
Assets
(INR Cr)
8768
4.2%
8419
7.8%
7809
2.7%
7604
3.2%
7367
10.5%
6670
3.6%
6437
7.5%
5990
-
9
-3.8%
10
-
Net Worth
(INR Cr)
5628
-3.1%
5810
4.7%
5549
-2.6%
5699
-0.3%
5715
6.3%
5379
5.3%
5107
6.1%
4814
0.0%
0
-160.7%
-1
0.0%
Employee Cost
(INR Cr)
1208
17.3%
1030
4.9%
981
12.4%
873
14.5%
762
6.7%
715
14.3%
625
4.9%
596
-
0
-
0
-
Interest Cost
(INR Cr)
1208657486257494911
Cash & Bank Balance
(INR Cr)
41318917230816196698710
Total Debt
(INR Cr)
2313220918301589135710421095950910

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS2024202320222021202020192018201720162015
Profit As % Of Revenues --0.8%-7.5%10.1%8.6%8.4%12.5%-
Profit As % Of Assets --0.2%-2.2%3.2%2.4%2.4%9.6%-
Profit As % Of Networth --0.3%-2.8%3.9%3.0%3.0%261.8%-
Interest Cost to EBITDA % 42.8%30.2%17.9%18.9%12.5%10.3%11.0%10.8%58.9%-
Debt to Equity Ratio 0.410.380.330.280.240.190.210.2026.41-
RONW --0.9%-2.9%4.0%3.1%3.0%261.8%-
ROCE 0.0%1.0%0.8%0.0%3.7%5.6%4.5%4.4%21.5%0.0%